Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View
02:18pm, Friday, 05'th Aug 2022
QuidelOrtho's (QDEL) robust performance across majority of its business units and geographies drives its second-quarter 2022 top line.
QuidelOrtho (QDEL) Q2 Earnings Miss Estimates
09:49pm, Thursday, 04'th Aug 2022
QuidelOrtho (QDEL) delivered earnings and revenue surprises of -42.55% and 7.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
QuidelOrtho Corporation (QDEL) CEO Douglas Bryant on Q2 2022 - Earnings Call Transcript
09:37pm, Thursday, 04'th Aug 2022
QuidelOrtho Corporation (NASDAQ:QDEL ) Q2 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman and CEO
QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022
04:05pm, Monday, 18'th Jul 2022
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for it
Can QuidelOrtho (QDEL) Keep the Earnings Surprise Streak Alive?
01:52pm, Tuesday, 12'th Jul 2022
QuidelOrtho (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Reasons to Add QuidelOrtho (QDEL) Stock to Your Portfolio Now
01:13pm, Tuesday, 05'th Jul 2022
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
5 Stocks With Robust Sales Growth to Beat Recession Woes
08:34am, Wednesday, 29'th Jun 2022
Steady sales growth is the key to survival for a business, even during recessions. Let's check at Boyd Gaming (BYD), Lithia Motors (LAD), Everest Re (RE), Jones Lang LaSalle (JLL) & QuidelOrtho (QDEL)
Is the Options Market Predicting a Spike in QuidelOrtho (QDEL) Stock?
09:59am, Monday, 27'th Jun 2022
Investors need to pay close attention to QuidelOrtho (QDEL) stock based on the movements in the options market lately.
QuidelOrtho (QDEL) Stock Jumps 3.9%: Will It Continue to Soar?
10:06am, Monday, 20'th Jun 2022
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here's Why You Should Retain QuidelOrtho (QDEL) Stock For Now
12:03pm, Wednesday, 01'st Jun 2022
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
Quidel (QDEL) Q1 Earnings, Revenues Surpass Estimates, Up Y/Y
12:47pm, Thursday, 05'th May 2022
Quidel's (QDEL) robust performance across two of its product categories drives its first-quarter 2022 top line.
Quidel Corporation (QDEL) CEO Doug Bryant on Q1 2022 Results - Earnings Call Transcript
09:41pm, Wednesday, 04'th May 2022
Quidel Corporation (NASDAQ:QDEL ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Ruben Argueta - Director, IR Doug Bryant - President and CEO Randy Steward - CFO Conferen
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates
07:34pm, Wednesday, 04'th May 2022
Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
01:32pm, Wednesday, 04'th May 2022
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?
01:32pm, Tuesday, 26'th Apr 2022
Quidel's (QDEL) first-quarter results are likely to reflect continued strength across its SARS-related products.
